Terminated × Esophageal Neoplasms × Gastrointestinal × Clear all PLATON
Terminated
565 enrolled
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
Phase 2 Terminated
6 enrolled
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Terminated
61 enrolled 29 charts
PAVO
Phase 2 Terminated
22 enrolled 17 charts
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Phase 1 Terminated
25 enrolled
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Phase 1 Terminated
10 enrolled
RAMIE vs OTE
Phase NA Terminated
24 enrolled
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Phase 1 Terminated
88 enrolled
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
Phase 1/2 Terminated
19 enrolled
AM-003
Phase 1 Terminated
5 enrolled
STARBURST
Phase 2 Terminated
11 enrolled
Lithium
Phase 1 Terminated
2 enrolled
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
Phase 1 Terminated
20 enrolled
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
Phase 1 Terminated
85 enrolled
Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening
Terminated
3 enrolled
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Phase 2 Terminated
54 enrolled 11 charts
A Study of SGN-STNV in Advanced Solid Tumors
Phase 1 Terminated
111 enrolled
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
Phase 1 Terminated
79 enrolled 42 charts
Oral AMXT 1501 Dicaprate in Combination With IV DFMO
Phase 1/2 Terminated
15 enrolled
Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis
Phase 2 Terminated
18 enrolled 13 charts
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
Phase 1/2 Terminated
13 enrolled 24 charts
EQLVCPAL
Terminated
31 enrolled
PROSPECT-ESO
Terminated
33 enrolled
A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer
Phase 2 Terminated
62 enrolled 28 charts
ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2)
Phase 2 Terminated
3 enrolled 15 charts
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
Phase NA Terminated
24 enrolled
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
Phase 1 Terminated
78 enrolled 39 charts
RESPECT
Phase NA Terminated
49 enrolled
A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma
Phase 2 Terminated
14 enrolled 11 charts
Early Detection of Esophageal Cancer
Terminated
6,864 enrolled
ORCA
Phase 1 Terminated
25 enrolled
REWARD
Terminated
30 enrolled
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Terminated
11 enrolled
BROTHER
Phase NA Terminated
1 enrolled
TORCH
Phase 1 Terminated
10 enrolled
Systems Biology of Gastrointestinal and Related Diseases
Terminated
17 enrolled
Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer
Phase 2 Terminated
11 enrolled 11 charts
Optimal Management of Malignant Dysphagia
Phase NA Terminated
3 enrolled
LODESTAR
Phase 2 Terminated
83 enrolled 16 charts
A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005
Phase 1 Terminated
11 enrolled 10 charts
FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Phase 1 Terminated
16 enrolled
A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors
Phase 1/2 Terminated
48 enrolled 20 charts
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts
A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer
Phase 1/2 Terminated
19 enrolled
Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas
Phase 1/2 Terminated
9 enrolled 14 charts
Staging of Superficial EAC Using VLE
Phase NA Terminated
30 enrolled 5 charts
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection
Phase 2 Terminated
1 enrolled 8 charts
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
Phase NA Terminated
12 enrolled
A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After Esophagectomy
Phase NA Terminated
38 enrolled
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
Phase 2 Terminated
137 enrolled 9 charts